Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Industry Veteran Launches New CRO, Dr. Vince Clinical Research, and Begins Headquarters Construction

Overland Park, KS., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Dr. Brad Vince announced he has founded a new clinical research organization and is building a cutting-edge headquarters and research complex in Kansas City. The organization, Dr. Vince Clinical Research, P.A., will formally commence clinical trials in summer 2022.

“Our goal is to create a world-class clinical pharmacology unit. We are constructing a green-certified facility from the ground up, investing in environmental performance and sustainability, technology and infrastructure so we can provide smarter, faster data to our biopharmaceutical clients. This innovative approach will fundamentally change the way Phase I trials are conducted,” stated CEO and Medical Director Brad Vince, D.O.

Dr. Vince is building a team of hand-selected key leaders to join him in accomplishing his vision. To attract and retain top research talent, the company is offering one of the most robust and comprehensive benefits packages in the region. The company also features a collaborative work environment and unrivaled amenities, designed to inspire dedicated employees who take pride in their work and provide unparalleled service for clients.

With more than 20 years experience in the clinical research industry, Dr. Vince has served as an Investigator in over 600 clinical trials and authored numerous scientific publications. He also has deep industry experience in government studies, including acting as Principal Investigator for various FDA and NIH trials. Dr. Vince is well-known in the industry for his passion, energy and 24/7/365 availability.


About Dr. Vince Clinical Research

Dr. Vince Clinical Research, P.A. (DVCR) is a world-class CRO (Contract Research Organization) with a custom-built, green-designed headquarters and research complex, encompassing three buildings in Overland Park, KS. DVCR’s complex includes a 90-bed clinical pharmacology unit, a GMP Pharmacy with positive and negative pressure compounding rooms and research suites for advanced medical procedures. DVCR specializes in conducting clinical trials in both healthy normal volunteers and patient populations, in a wide variety of early phase clinical trials as well as studies with outpatient visits. By leveraging both technology and a seasoned leadership team, DVCR can provide Smarter, Faster Data TM to biopharmaceutical clients.




Zach Bader
Dr. Vince Clinical Research
[email protected]

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).